Literature DB >> 5564684

"Upper limits of normal" antistreptolysin O and antideoxyribonuclease B titers.

G C Klein, C N Baker, W L Jones.   

Abstract

"Upper limits of normal" antistreptolysin O (ASO) and antideoxyribonuclease (ADN) B titers were determined on serum specimens from various age groups of pediatric patients with no history of a recent streptococcal infection and on healthy adult hospital employees. The upper limit of normal value is that level of antibody titer exceeded by no more than 15% of the total subjects in each age group. This value varies with the age of the subject, and the most pronounced differences are between the values of preschool age children, school age children, and adults. The upper limit of normal values for these groups were as follows: preschool age, ASO = 85(100); ADN B = 60(50); school age, ASO = 170(166); ADN B=1 70(166); and adult, ASO = 85(100); ADN B = 85(100).

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5564684      PMCID: PMC377331          DOI: 10.1128/am.21.6.999-1001.1971

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  3 in total

1.  Antibody titers in acute rheumatic fever.

Authors:  L W WANNAMAKER; E M AYOUB
Journal:  Circulation       Date:  1960-04       Impact factor: 29.690

2.  Micro antistreptolysin O test.

Authors:  G C Klein; M D Moody; C N Baker; B V Addison
Journal:  Appl Microbiol       Date:  1968-01

3.  Micro test for streptococcal anti-deoxyribonuclease B.

Authors:  G C Klein; C N Baker; B V Addison; M D Moody
Journal:  Appl Microbiol       Date:  1969-08
  3 in total
  15 in total

1.  Discrepancy between results of the Streptozyme test and those of the antideoxyribonulcease B and antihyaluronidase tests.

Authors:  B Hederstedt; S E Holm; T Wadstrom
Journal:  J Clin Microbiol       Date:  1978-07       Impact factor: 5.948

2.  Upper limit of normal titer for detection of antibodies to Legionella pneumophila by the microagglutination test.

Authors:  G C Klein; W L Jones; J C Feeley
Journal:  J Clin Microbiol       Date:  1979-11       Impact factor: 5.948

3.  Detection of antibodies to Afipia species by the microagglutination test.

Authors:  H E Müller
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-12       Impact factor: 3.267

4.  Indirect immunofluorescence antibodies to Legionella pneumophila: frequency in a rural community.

Authors:  C M Helms; E D Renner; J P Viner; W J Hierholzer; L A Wintermeyer; W Johnson
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948

5.  Background prevalence of microagglutination antibodies to Legionella pneumophila serogroups 1, 2, 3, and 4.

Authors:  C M Helms; W Johnson; E D Renner; W J Hierholzer; L A Wintermeyer; J P Viner
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

6.  Normal ranges of streptococcal antibody titers are similar whether streptococci are endemic to the setting or not.

Authors:  Andrew C Steer; Suzanna Vidmar; Roselyn Ritika; Joseph Kado; Michael Batzloff; Adam W J Jenney; John B Carlin; Jonathan R Carapetis
Journal:  Clin Vaccine Immunol       Date:  2008-12-03

7.  Asymptomatic infection by Streptococcus pyogenes in schoolchildren and diagnostic usefulness of antideoxyribonuclease B.

Authors:  Sunjoo Kim; Nam Yong Lee
Journal:  J Korean Med Sci       Date:  2005-12       Impact factor: 2.153

8.  Use of available dosage forms of cephalexin in clinical comparison with phenoxymethyl penicillin and benzathine penicillin in the treatment of streptococcal pharyngitis in children.

Authors:  J M Matsen; O Torstenson; S E Siegel; H Bacaner
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

9.  Cross-reaction to Legionella pneumophila antigen in sera with elevated titers to Pseudomonas pseudomallei.

Authors:  G C Klein
Journal:  J Clin Microbiol       Date:  1980-01       Impact factor: 5.948

10.  Detection of antibodies against Legionella pneumophila serogroups 1 to 6 and the Leiden-1 strain by micro ELISA and immunofluorescence assay.

Authors:  P Herbrink; P L Meenhorst; D G Groothuis; H V Munckhof; R Bax; C J Meijer; J Lindeman
Journal:  J Clin Pathol       Date:  1983-11       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.